OPA quantification of amino groups at the surface of lipidic nanocapsules (LNCs) for ligand coupling improvement.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  International journal of pharmaceutics

• Publication date

  2011-10-31

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1016/j.ijpharm.2011.07.028PMID 21839821
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Converging toward a common speech code: imitative and perceptuo-motor recalibration processes in speech production

  2013cited by this paper
• Post-insertion into Lipid NanoCapsules (LNCs): From experimental aspects to mechanisms.

  2010cited by this paper
• Advancing nonviral gene delivery: lipid- and surfactant-based nanoparticle design strategies.

  2010cited by this paper
• Methods for the functionalisation of nanoparticles: new insights and perspectives.

  2010cited by this paper
• Non-viral nanosystems for systemic siRNA delivery.

  2010cited by this paper
• Nanomedicine--challenge and perspectives.

  2009cited by this paper
• Galactosylated DNA lipid nanocapsules for efficient hepatocyte targeting.

  2009cited by this paper
• A review of stimuli-responsive nanocarriers for drug and gene delivery.

  2008cited by this paper
• Multi-functional nanocarriers to overcome tumor drug resistance.

  2008cited by this paper
• Mannose-targeted systems for the delivery of therapeutics

  2008cited by this paper
• Therapeutic Nanoparticles for Drug Delivery in Cancer

  2008cited by this paper
• Nanoparticle therapeutics: an emerging treatment modality for cancer

  2008cited by this paper
• Multifunctional magnetic nanoparticles for targeted imaging and therapy.

  2008cited by this paper
• Polymers and nanoparticles: intelligent tools for intracellular targeting?

  2008cited by this paper
• The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform.

  2007cited by this paper
• Programmed drug delivery: nanosystems for tumor targeting

  2007cited by this paper
• Nanotechnology applications in cancer.

  2007cited by this paper
• Multifunctional nanocarriers.

  2006cited by this paper
• A simply and sensitive fluorometric method for determination of gentamicin in liposomal suspensions.

  2006cited by this paper
• Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery

  2006cited by this paper
• Multi-functional polymeric nanoparticles for tumour-targeted drug delivery

  2006cited by this paper
• Nanoparticle–aptamer bioconjugates for cancer targeting

  2006cited by this paper
• Recent Developments in the Application of Plasmid DNA-Based Vectors and Small Interfering RNA Therapeutics for Cancer

  2006cited by this paper
• Engineered nanoparticles as precise drug delivery systems

  2006cited by this paper
• Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.

  2006cited by this paper
• A model for describing the thermodynamics of multivalent host-guest interactions at interfaces.

  2004cited by this paper
• Nanoparticles of biodegradable polymers for new-concept chemotherapy

  2004cited by this paper
• Drug Delivery Systems: Entering the Mainstream

  2004cited by this paper
• On the nature of the multivalency effect: a thermodynamic model.

  2003cited by this paper
• Biodegradable nanoparticles for drug and gene delivery to cells and tissue.

  2003cited by this paper
• The influence of lipid nanocapsule composition on their size distribution.

  2003cited by this paper
• Cell-penetrating Peptides

  2003cited by this paper
• A Novel Phase Inversion-Based Process for the Preparation of Lipid Nanocarriers

  2002cited by this paper
• Properties of polyethylene glycol 660 12-hydroxy stearate at a triglyceride/water interface.

  2002cited by this paper
• Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

  2001cited by this paper
• Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors.

  1998cited by this paper
• αv Integrins as receptors for tumor targeting by circulating ligands

  1997cited by this paper
• A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus*

  1997cited by this paper
• Brain drug delivery of small molecules using immunoliposomes.

  1996cited by this paper
• Transfer of Genes to Humans: Early Lessons and Obstacles to Success

  1995cited by this paper
• Tat-mediated delivery of heterologous proteins into cells.

  1994cited by this paper
• New perspectives in cell adhesion: RGD and integrins.

  1987cited by this paper
• The Binding Avidity of a Nanoparticle-based Multivalent Targeted Drug Delivery Platform

  year unknowncited by this paper

• Improvement in phenotype homeostasis of macrophages by chitosan nanoparticles and subsequent impacts on liver injury and tumor treatment.

  2021cites this paper
• Strategies for High Grafting Efficiency of Functional Ligands to Lipid Nanoemulsions for RGD-Mediated Targeting of Tumor Cells In Vitro.

  2020cites this paper
• Nano- and microparticles as drug carriers

  2020cites this paper
• Self-assembled nanomaterials

  2018cites this paper
• Cytotoxicity and genotoxicity of lipid nanocapsules.

  2017cites this paper
• Lipid based nanocapsules: a multitude of biomedical applications.

  2015cites this paper
• Anti-epidermal growth factor receptor siRNA carried by chitosan-transacylated lipid nanocapsules increases sensitivity of glioblastoma cells to temozolomide

  2014cites this paper
• Preparation and characterization of alginate gel core-lipid nanocapsules for co-delivery of hydrophilic and hydrophobic anti-cancer drugs

  2014cites this paper
• Surface modification of lipid nanocapsules with polysaccharides: from physicochemical characteristics to in vivo aspects.

  2013cites this paper